A Misleading Parameter in the Diagnosis of Chronic Hepatitis B: Persistently Normal Transaminases
Journal Title: Viral Hepatitis Journal - Year 2018, Vol 24, Issue 3
Abstract
Objectives: Most of the patients with hepatitis B e (HBe)-negative hepatitis B have persistently normal transaminases (PNALT) levels. Patients, who have higher fibrosis and necroinflammatory activity scores, are at high risk for hepatocellular carcinoma and cirrhosis. Therefore, it is important to distinguish between active and inactive hepatitis in this group. Materials and Methods: Sixty-six treatment-naïve, non-cirrotic, HBe antigen (HBeAg)-negative and a PNALT and a level of a hepatitis B virus (HBV) DNA level of ≥2000 IU/mL were included in this study. Ishak’s scoring system was used for histopathological evaluation. Chronic hepatitis was defined as a fibrosis score of higher than/ equal to 2 and/or a histological activity index score of higher than 4. Results: The percentage of patients diagnosed with advanced fibrosis score and high necroinflammatory activity was 65% and 48%, respectively. Accordingly, 76% of patients were considered to have chronic hepatitis. Level of the HBV DNA was the most significant value for predicting chronic hepatitis. 94.1% of patients with a HBV DNA value over 20000 IU/mL had chronic hepatitis (p<0.001). Conclusion: As a result of this study, it has been found that the prevalence of chronic hepatitis in our country was high in HBeAgnegative patients with PNALT and a HBV DNA level higher than 2000 IU/mL. We recommend starting treatment in patients with a HBV DNA level higher than 20000 IU/mL without considering any other criteria. Close monitoring or biopsy is recommended in patients with HBV DNA values between 2000 and 20000 IU/mL.
Authors and Affiliations
Osman ÖZDOĞAN, Serkan YARAŞ, Ali Riza KÖKSAL, Engin ALTINKAYA, Mehmet BAYRAM, Banu YILMAZ ÖZGÜVEN, Canan ALKIM
Keywords
Related Articles
- EP ID EP427181
- DOI 10.4274/vhd.2018.0010
- Views 42
- Downloads 0
A Case of Hepatitis B Reactivation with Acute Flare Three Months After Tenofovir Prophylaxis Withdrawal in a Allogenic Hematopoietic Stem Cell Transplantation Patient
Hepatitis B virus (HBV) infection is a major health problem worldwide. HBV reactivation is associated with high mortality rates in hematopoietic stem cell transplantation (HSCT) and, prophylactic antiviral treatment is s...
Failure of Direct-Acting Antiviral Agents Due to Incomplete Hepatitis C Virus Genotyping
Current direct-acting antivirals (DAAs) have high success rates in the treatment of chronic hepatitis C virus (HCV) infection. However, 1-15% of patients fail to achieve viral eradication. Some factors may play a role in...
Percutaneous Liver Needle Biopsy Methods Can Be Safe and Effective in Patients with Viral Hepatitis
Objectives: The aims of this study were to evaluate the biopsy methods used in terms of safety, and effectiveness as well as incidence, and severity of complications. Materials and Methods: This study was conducted as a...
Hepatitis B Virus Vaccination Rates among Medical Laboratory Workers: A Multi-centered Assessment
Objective: In this multicenter study, we aimed to determine the rates of hepatitis B virus (HBV) in medical laboratory workers in Turkey and to discuss the current status. Materials and Methods: We designed this study as...
Which One Should Be Prefered: Liver Biopsy or Non-Invasive Procedures?
.